JG
Congress trade
Rep. Josh Gottheimer (D-NJ) bought $1K-$15K of Abbott Laboratories (ABT) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a purchase of Abbott Laboratories (ABT) stock worth $1K-$15K in a STOCK Act filing on Sep 11, 2024.
The trade happened on Aug 19, 2024, 23 days before it was made public.
ABT has moved -12.9% since the trade date, from $111.90 to $97.50 (Oct 2, 2026 close).
- Traded
- Aug 19, 2024
- Disclosed
- Sep 11, 2024
- Filing delay
- 23 days
- Price since
- -12.9%
- Source
- STOCK Act disclosure
Other trades in this disclosure (31)
- BuyMSFT$15K-$50KSep 11, 2024
- SellMSFT$15K-$50KSep 11, 2024
- BuyAAPL$1K-$15KSep 11, 2024
- SellAMD$1K-$15KSep 11, 2024
- SellAMD$1K-$15KSep 11, 2024
- SellAPD$1K-$15KSep 11, 2024
- SellBKNG$1K-$15KSep 11, 2024
- SellBNTX$1K-$15KSep 11, 2024
- BuyBRK.B$1K-$15KSep 11, 2024
- SellCHUY$1K-$15KSep 11, 2024
- SellETN$1K-$15KSep 11, 2024
- BuyFWRG$1K-$15KSep 11, 2024
- BuyGS$1K-$15KSep 11, 2024
- BuyGS$1K-$15KSep 11, 2024
- SellHSHCY$1K-$15KSep 11, 2024
- SellJBL$1K-$15KSep 11, 2024
- BuyKO$1K-$15KSep 11, 2024
- BuyKO$1K-$15KSep 11, 2024
- SellLOW$1K-$15KSep 11, 2024
- SellMAR$1K-$15KSep 11, 2024
More ABT insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.